The Market for Erectile Dysfunction Treatments is Hot: How To Tap Into The Market Share


On this episode of Turbo Charged MD, we discuss the upward trend in Erectile Dysfunction treatments,  more specifically, non medication related treatment and therapies.  Topics include:
  • The FDA approved Viagra in 1998. Pfizers marketing investment blew open the conversation about ED.
  • Men and Women are more open to discussing the issues and challenges.
  • PDE5 inhibitors do not address the root cause of ED (poor blood flow)  and have many side affects. Same with Tri-Mix and Quad-Mix. 
  • Men are asking questions like: Why do I have ED, could my ED have been prevented, or is it just an inevitable consequence of aging? Is my ED a condition in its own right, to be treated with PDE5 inhibitors and left at that, or is it a sign that I may have other problems that need attention, extending to therapies other than or in addition to Viagra? If ED is just another discomfiting aspect of normal aging, is it impossible for my ED to regress? Or will I need to take PDE5 Inhibitors for the rest of my life?
  • Over 30 million men in the US have ED.’
  • ED issues are relationship driven. 
  • What alternative therapies are there?
  • Low Intensity Acoustic Wave Therapy, Priapus Shot, Stem Cells and Exosomes.
  • The ED market revenues are almost $5 billion headed to $7 billion by 2024.
  • How to monetize the market into your practice.
close slider